QH101 cell therapy for brain and spinal cord metastases
Part of Brain & nervous system, Cancer clinical trials.
This trial tests an experimental cell therapy called QH101 for people whose cancer has spread to the brain, spinal cord, or the membranes around them, and who have no standard treatment options left. The goal is to see if this treatment can shrink tumors or slow their growth.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- Your cancer has spread to the brain, spinal cord, or the lining around these areas, and standard treatments have stopped working or aren't available.
- You are well enough to be up and about (ECOG score 0-2 or Karnofsky score 60 or higher).
- You have had a recent MRI showing at least one measurable tumor in the brain or spinal cord, or you have only tumor in the lining and your doctor thinks the treatment might help.
- Your blood counts and liver and kidney function are within certain limits (your doctor will check these).
- You agree to use effective birth control during the study and for one year afterward if you could become pregnant or father a child.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an experimental cell therapy (HS-IT101) for people with advanced solid tumors that have not responded to standard treatments. It uses immune cells from your own tumor to fight cancer, and researchers want to see if it is safe and effective.
This trial tests a new drug, NBQ72S, for people with breast cancer that has spread to the lining of the brain or spinal cord (leptomeningeal metastasis). It aims to see if the drug is safe and helpful for these patients.
This trial tests a new drug called MT027 for people whose solid tumors (like lung or breast cancer) have spread to the brain, spinal cord, or their protective lining. The goal is to see if it is safe and helps shrink or control these metastases.
This trial tests a new cancer medication for people with head and neck cancer that has come back or spread to other parts of the body. The study aims to see if this drug can help slow or shrink the cancer and improve survival.
This trial tests a new cell therapy (P134 cells) for people whose glioblastoma has come back after standard treatments like radiation or chemotherapy. The therapy uses a patient's own immune cells (PBMCs) to target cancer cells that have specific markers (CD44 or CD133). It also requires a small procedure to place a reservoir under the scalp for drug delivery.
This trial tests a new cell therapy called CHT102 for people with advanced solid tumors that have a certain marker (mesothelin). The treatment is for those who haven't responded to standard therapy or who don't have a standard first-line option.
Hear when a new Brain Metastasis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.